Tesla Exceeds Delivery Expectations and Sees Stock Jump

July 2, 2024

Tesla reported a 5% drop in vehicle deliveries in the second quarter, with approximately 411,000 vehicles produced and 444,000 delivered, surpassing expectations and leading to a 10% stock jump. The company's financial results for the quarter will be released on July 23, 2024. Tesla's stock rose 8.8% to $228.29 after the report, and before the report, shares were down 16% in 2024. The company's deliveries fell 4.8% from a year earlier but rose 14.8% from the first quarter. Tesla's lineup includes the Model Y, Model 3, Cybertruck, Model X, and Model S. The first-quarter decline in deliveries was attributed to temporary factory shutdowns and shipping delays. The company faced competition from Chinese counterparts and initiated cost-cutting measures. CEO Elon Musk acknowledged challenges in the EV market and competitors scaling back their investments. Analysts noted that Tesla's gross margin would likely be impacted amid a crowded market. The company's production and deliveries dropped compared to the previous year, continuing a trend of declining sales. Tesla attributed the drop in deliveries to increased competition, production issues, and a limited vehicle lineup. The company's market share has decreased, and its sales continue to drop despite double-digit growth in EV sales reported by other automakers. The majority of Tesla's sales come from the Model 3 and Model Y, while the Cybertruck has faced challenges. Tesla's financial performance depends on various factors, including average selling price, cost of sales, and foreign exchange movements. The company's net income and cash flow results will be announced with its financial performance for the quarter. Tesla's stock jumped 5% after it reported quarterly vehicle deliveries that beat analyst expectations, delivering 443,956 vehicles in the second quarter. The company's financial results for the quarter will be released on July 23, 2024, and a live question and answer webcast will be held to discuss the results and outlook.

Additional Coverage
Supplimental Context